Nash Drug Company Limited
Nash Drug Company Limited is a dormant company incorporated on 7 April 1978 with the registered office located in Bolton, Greater Manchester. Nash Drug Company Limited was registered 47 years ago.
Status
Dormant
Dormant since 7 years ago
Company No
01361825
Private limited company
Age
47 years
Incorporated 7 April 1978
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 10 March 2025 (7 months ago)
Next confirmation dated 10 March 2026
Due by 24 March 2026 (5 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 May ⟶ 30 Apr 2024 (1 year)
Accounts type is Dormant
Next accounts for period 30 April 2025
Due by 31 January 2026 (3 months remaining)
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Colin Caunce, Andrew John Caunce, and 1 more are mutual people.
Active
Colin Caunce, Andrew John Caunce, and 1 more are mutual people.
Active
Andrew John Caunce and Gorgemead Limited are mutual people.
Active
Andrew John Caunce and Gorgemead Limited are mutual people.
Active
Andrew John Caunce and Gorgemead Limited are mutual people.
Active
Andrew John Caunce and Gorgemead Limited are mutual people.
Active
Andrew John Caunce and Gorgemead Limited are mutual people.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Apr 2024
For period 30 Apr ⟶ 30 Apr 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£237.54K
Same as previous period
Total Liabilities
£0
Same as previous period
Net Assets
£237.54K
Same as previous period
Debt Ratio (%)
0%
Same as previous period
Get Credit Report
Discover Nash Drug Company Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
